Correlation Engine 2.0
Clear Search sequence regions

  • CYP2C9 (15)
  • flurbiprofen (8)
  • genotypes (7)
  • P 450 (2)
  • Sizes of these terms reflect their relevance to your search.

    The aim of this study was to establish the physiologically based pharmacokinetic (PBPK) model of flurbiprofen related to CYP2C9 genetic polymorphism and describe the pharmacokinetics of flurbiprofen in different CYP2C9 genotypes. PK-Sim® software was used for the model development and validation. A total of 16 clinical pharmacokinetic data for flurbiprofen in different CYP2C9 genotypes, dose regimens, and age groups were used for the PBPK modeling. Turnover number (kcat) of CYP2C9 values were optimized to capture the observed profiles in different CYP2C9 genotypes. In the simulation, predicted fraction metabolized by CYP2C9, fraction excreted to urine, bioavailability, and volume of distribution were similar to previously reported values. Predicted plasma concentration-time profiles in different CYP2C9 genotypes were visually similar to the observed profiles. Predicted AUCinf in CYP2C9*1/*2, CYP2C9*1/*3, and CYP2C9*3/*3 genotypes were 1.44-, 2.05-, and 3.67-fold higher than the CYP2C9*1/*1 genotype. The ranges of fold errors for AUCinf, Cmax, and t1/2 were 0.84-1.00, 0.61-1.22, and 0.74-0.94 in development and 0.59-0.98, 0.52-0.97, and 0.61-1.52 in validation, respectively, which were within the acceptance criterion. Thus, the PBPK model was successfully established and described the pharmacokinetics of flurbiprofen in different CYP2C9 genotypes, dose regimens, and age groups. The present model could guide the decision-making of tailored drug administration strategy by predicting the pharmacokinetics of flurbiprofen in various clinical scenarios. © 2022. The Pharmaceutical Society of Korea.


    Sang-Sup Whang, Chang-Keun Cho, Eui Hyun Jung, Pureum Kang, Hye-Jung Park, Yun Jeong Lee, Chang-Ik Choi, Jung-Woo Bae, Hyung Sik Kim, Choon-Gon Jang, Seok-Yong Lee. Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes. Archives of pharmacal research. 2022 Aug;45(8):584-595

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 36028591

    View Full Text